Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Genetically modified HUCPVCs created at Tissue Regeneration Therapeutics

Jan. 25, 2018

Dupixent approved in Japan for treatment of atopic dermatitis

Jan. 22, 2018

Almirall presents novel JAK inhibitors

Jan. 17, 2018

FDA accepts NDA for IDP-121 lotion for acne

Jan. 15, 2018

Toray and 3SBio enter license agreement for orally disintegrating formulation of TRK-820 in China

Jan. 15, 2018

Topline results from Japanese phase III study of JTE-052 in atopic dermatitis

Jan. 15, 2018

FDA grants fast track designation to CTP-543 for moderate to severe alopecia areata

Jan. 15, 2018

UCB studies bimekizumab in phase III for moderate to severe chronic plaque psoriasis

Jan. 12, 2018

AbbVie's upadacitinib awarded FDA breakthrough therapy designation for atopic dermatitis

Jan. 9, 2018

Jiangsu Hengrui Medicine grants SHR-0302 rights to Arcutis for dermatology disorders

Jan. 8, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...